| CAT # | Inoa Huahana | wehewehe |
| CPD0004 | ʻO Ertugliflozin | ʻO Ertugliflozin, i ʻike ʻia hoʻi ʻo PF-04971729, he mea hoʻomalu a koho i ka sodium-dependent glucose cotransporter 2 a me ka moho lapaʻau no ka mālama ʻana i ka maʻi diabetes type 2. |
| CPDA0048 | ʻO Omarigliptin | ʻO Omarigliptin, ʻike ʻia hoʻi ʻo MK-3102, he mea hoʻopaneʻe DPP-4 ikaika a lōʻihi no ka mālama ʻana i hoʻokahi pule o ka maʻi diabetes type 2. |
| CPDA1089 | Retagliptin | ʻO Retagliptin, i kapa ʻia ʻo SP-2086, he mea hoʻopaneʻe DPP-4 hiki ke hoʻohana ʻia no ka mālama ʻana i ka maʻi maʻi type 2. |
| CPDA0088 | ʻO Trelagliptin | ʻO Trelagliptin, ka mea i ʻike ʻia ʻo SYR-472, he hana lōʻihi o ka dipeptidyl peptidase-4 (DPP-4) inhibitor i kūkulu ʻia e Takeda no ka mālama ʻana i ka maʻi diabetes type 2 (T2D). |
| CPDA2039 | Linagliptin | ʻO Linagliptin, ka mea i kapa ʻia ʻo BI-1356, he mea pale DPP-4 i hoʻomohala ʻia e Boehringer Ingelheim no ka mālama ʻana i ka maʻi diabetes type II. |
| CPDA0100 | ʻO Sitagliptin | ʻO Sitagliptin (INN; i ʻike mua ʻia ʻo MK-0431 a kūʻai ʻia ma lalo o ka inoa kalepa ʻo Januvia) he lāʻau antihyperglycemic waha (anti-diabetic drug) o ka papa dipeptidyl peptidase-4 (DPP-4) inhibitor. |
| CPD0854 | LX-4211 | ʻO LX-4211 kahi mea hoʻopaneʻe SGLT2/1 ikaika; Nā lāʻau antidiabetic. |
| CPDA1553 | LX-2761 | ʻO LX2761 kahi mea hoʻopaneʻe SGLT1 hana kūloko i ikaika loa i loko o ka vitro a hoʻopaneʻe i ka absorption glucose intestinal in vivo e hoʻomaikaʻi i ka mana glycemic. |
